These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 22003054

  • 1. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
    Zhang T, Li Z, Dang H, Chen R, Liaw C, Tran TA, Boatman PD, Connolly DT, Adams JW.
    Am J Physiol Heart Circ Physiol; 2012 Jan 01; 302(1):H299-311. PubMed ID: 22003054
    [Abstract] [Full Text] [Related]

  • 2. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE.
    Basic Res Cardiol; 2007 Jul 01; 102(4):350-8. PubMed ID: 17468933
    [Abstract] [Full Text] [Related]

  • 3. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.
    Strande JL, Widlansky ME, Tsopanoglou NE, Su J, Wang J, Hsu A, Routhu KV, Baker JE.
    Cardiovasc Res; 2009 Jul 15; 83(2):325-34. PubMed ID: 19380418
    [Abstract] [Full Text] [Related]

  • 4. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z, Tong G, Ma N, Li J, Li X, Li S, Zhou J, Xiong L, Cao F, Yao L, Wang H, Shen L.
    Basic Res Cardiol; 2013 May 15; 108(3):341. PubMed ID: 23463182
    [Abstract] [Full Text] [Related]

  • 5. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
    Zhong B, Wang DH.
    Am J Physiol Regul Integr Comp Physiol; 2009 Dec 15; 297(6):R1681-90. PubMed ID: 19812353
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
    Obana M, Miyamoto K, Murasawa S, Iwakura T, Hayama A, Yamashita T, Shiragaki M, Kumagai S, Miyawaki A, Takewaki K, Matsumiya G, Maeda M, Yoshiyama M, Nakayama H, Fujio Y.
    Am J Physiol Heart Circ Physiol; 2012 Sep 01; 303(5):H569-77. PubMed ID: 22707562
    [Abstract] [Full Text] [Related]

  • 7. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression.
    Bhuiyan MS, Shibuya M, Shioda N, Moriguchi S, Kasahara J, Iwabuchi Y, Fukunaga K.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):180-8. PubMed ID: 17658509
    [Abstract] [Full Text] [Related]

  • 8. Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning.
    Abwainy A, Babiker F, Akhtar S, Benter IF.
    Am J Physiol Heart Circ Physiol; 2016 Jan 01; 310(1):H104-12. PubMed ID: 26519026
    [Abstract] [Full Text] [Related]

  • 9. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
    Hamid SA, Bower HS, Baxter GF.
    Am J Physiol Heart Circ Physiol; 2007 Jun 01; 292(6):H2598-606. PubMed ID: 17220176
    [Abstract] [Full Text] [Related]

  • 10. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
    Park ES, Kang DH, Yang MK, Kang JC, Jang YC, Park JS, Kim SK, Shin HS.
    Cardiovasc Toxicol; 2014 Mar 01; 14(1):1-9. PubMed ID: 24178833
    [Abstract] [Full Text] [Related]

  • 11. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
    García-Prieto J, García-Ruiz JM, Sanz-Rosa D, Pun A, García-Alvarez A, Davidson SM, Fernández-Friera L, Nuno-Ayala M, Fernández-Jiménez R, Bernal JA, Izquierdo-Garcia JL, Jimenez-Borreguero J, Pizarro G, Ruiz-Cabello J, Macaya C, Fuster V, Yellon DM, Ibanez B.
    Basic Res Cardiol; 2014 Jul 01; 109(4):422. PubMed ID: 24951958
    [Abstract] [Full Text] [Related]

  • 12. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
    Duan W, Yang Y, Yan J, Yu S, Liu J, Zhou J, Zhang J, Jin Z, Yi D.
    Basic Res Cardiol; 2012 May 01; 107(3):263. PubMed ID: 22466958
    [Abstract] [Full Text] [Related]

  • 13. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function.
    Audia JP, Yang XM, Crockett ES, Housley N, Haq EU, O'Donnell K, Cohen MV, Downey JM, Alvarez DF.
    Basic Res Cardiol; 2018 Jul 10; 113(5):32. PubMed ID: 29992382
    [Abstract] [Full Text] [Related]

  • 14. Cardioprotection provided by Echinatin against ischemia/reperfusion in isolated rat hearts.
    Tian XH, Liu CL, Jiang HL, Zhang Y, Han JC, Liu J, Chen M.
    BMC Cardiovasc Disord; 2016 May 31; 16():119. PubMed ID: 27246834
    [Abstract] [Full Text] [Related]

  • 15. Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes.
    Lieder HR, Braczko F, Gedik N, Stroetges M, Heusch G, Kleinbongard P.
    Basic Res Cardiol; 2021 Apr 19; 116(1):27. PubMed ID: 33876304
    [Abstract] [Full Text] [Related]

  • 16. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats.
    Deschamps AM, Murphy E.
    Am J Physiol Heart Circ Physiol; 2009 Nov 19; 297(5):H1806-13. PubMed ID: 19717735
    [Abstract] [Full Text] [Related]

  • 17. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
    Bao W, Holt LJ, Prince RD, Jones GX, Aravindhan K, Szapacs M, Barbour AM, Jolivette LJ, Lepore JJ, Willette RN, DeAngelis E, Jucker BM.
    Cardiovasc Diabetol; 2013 Oct 14; 12():148. PubMed ID: 24125539
    [Abstract] [Full Text] [Related]

  • 18. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC, Bovens SM, de Jager SC, van Middelaar BJ, van Duijvenvoorde A, Doevendans PA, Pasterkamp G, de Kleijn DP, Timmers L.
    Cardiovasc Res; 2015 Dec 01; 108(3):367-76. PubMed ID: 26449403
    [Abstract] [Full Text] [Related]

  • 19. Cardioprotection with alpha-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation.
    Mukherjee S, Lekli I, Das M, Azzi A, Das DK.
    Biochim Biophys Acta; 2008 Sep 01; 1782(9):498-503. PubMed ID: 18555028
    [Abstract] [Full Text] [Related]

  • 20. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S, Ghaboura N, Treguer F, Khachman D, Croué A, Henrion D, Furber A, Prunier F.
    Am J Physiol Heart Circ Physiol; 2009 Dec 01; 297(6):H2035-43. PubMed ID: 19617412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.